XIVER develops and manufactures advanced micro- and nanosystems for applications across photonics, high-speed data communication, medical technology and defence. The company scales prototypes to industrial production and supplies international market leaders, including ASML, with thin-film microcomponents and membranes. Following a carve-out from Royal Philips in early 2025, XIVER has pursued strategic partnerships in Europe and North America. With the recent €25 million growth capital raise and an expected €25 million credit facility, XIVER is investing in a new 8-inch DUV production line to increase output and reduce lead times. This expansion is intended to meet rapidly growing global demand driven by AI and to strengthen European onshore semiconductor production capacity.

Total raised

$29M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2026